Intellia Therapeutics Inc.

NAS: NTLA

GO
/marketstate/country/us

Before the Bell

 --Quotes are delayed by 20 min

Jun 27, 2022, 7:00 a.m.

/zigman2/quotes/207821052/composite

$

53.90

Change

+0.49 +0.92%

Volume

Volume 316

Quotes are delayed by 20 min

/zigman2/quotes/207821052/composite

Previous close

$ 53.41

$ 53.41

Change

+2.65 +5.22%

Day low

Day high

$49.30

$55.23

Open

52 week low

52 week high

$37.08

$202.73

Open

Fred Ehrenkranz Cohen

Founder of 6 different companies, including: Kyverna Therapeutics, Inc., Monograph Capital Partners I LP and TPG Biotechnology Partners LP, Fred Ehrenkranz Cohen and presently occupies the position of Senior Managing Director at VV Manager LLC (which he founded in 2017) and Chairman of Monograph Capital Partners I LP (which he founded in 2021). Dr. Cohen is also Member of American Academy of Arts & Sciences, Member of National Academy of Medicine (United States), Member of Association of American Physicians, Member of American Society for Clinical Investigation, Member of National Academy of Medicine and Managing Director & Partner at Tarrant Capital IP LLC and on the board of 14 other companies.

In his past career he was Director at Rapid Micro Biosystems, Inc., Chairman for Cell Design Labs, Inc. (he founded the company in 2016), Senior Director-Business Development at Kosan Biosciences, Inc., Managing Director at The Plastics Group, Inc., Managing Director & Partner at TPG Biotechnology Partners LP (he founded the company in 2001), Senior Managing Partner at Vida Ventures LLC (he founded the company in 2017), Advisor at CHV Capital, Inc., Partner at TPG Capital LLC and Professor at The University of California, San Francisco.

He received an undergraduate degree from Yale University, a doctorate from the University of Oxford and a doctorate from Stanford University.

Transactions

Date Shares Transaction Value
06/14/2022 5,197   Award at $0 per share. 0
06/23/2021 2,094   Award at $0 per share. 0
01/20/2021 20,000   Derivative/Non-derivative trans. at $13.78 per share. 275,600
03/01/2019 10,000   Award at $16.89 per share. 168,900

Officers and Executives

Dr. John M. Leonard
President, Chief Executive Officer & Director
Mr. Glenn Goddard
Treasurer, Chief Financial & Accounting Officer
Dr. Laura Sepp-Lorenzino
Chief Scientific Officer & Executive VP
Dr. Eliana Clark
Chief Technology Officer & Executive VP
Dr. David Lebwohl
Chief Medical Officer & Executive Vice President
Dr. Christine Foster
SVP-Business Development & Alliance Management
Mr. Derek Hicks
Chief Business Officer & Executive Vice President
Mr. Ian Karp
Senior Vice President-Corporate Communications
Ms. Marika St Amand
Chief Human Resources Officer
Mr. James Basta
Secretary, Executive VP & General Counsel
Dr. Frank A. G. M. Verwiel
Chairman
Mr. John Francis Crowley
Independent Director
Dr. Georgia Keresty
Independent Director
Ms. Muna Bhanji
Independent Director
Dr. Jean-Francois B. Formela
Independent Director
Ms. Caroline D. Dorsa
Independent Director
Dr. Jesse L. Goodman
Independent Director
Dr. Fred Ehrenkranz Cohen
Independent Director
Link to MarketWatch's Slice.